Search research articles
Contact Us
Filters
Showing results (241-250 of 286) with videos related to
Page
of 29
Sort By:
The Journal of Antimicrobial Chemotherapy
|
March 28, 2025
Population pharmacokinetics and exposure-response relationship of the antituberculosis drug BTZ-043
Simon E Koele, Norbert Heinrich, Veronique R De Jager, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 7, 2024
Diagnostic accuracy of TB screening tests in a prospective multinational cohort: Chest-X-ray with computer-aided detection, Xpert TB host response, and C-reactive protein
Rebecca Crowder, Balamugesh Thangakunam, Alfred Andama, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2023
Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
Ralf Stemkens, Veronique de Jager, Rodney Dawson, et al.
The New England Journal of Medicine
|
March 14, 2019
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew J Nunn, Patrick P J Phillips, Sarah K Meredith, et al.
BMC Infectious Diseases
|
August 17, 2017
Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil
D M P Ramalho, P F C Miranda, M K Andrade, et al.
BMC Medicine
|
March 30, 2018
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
Conor Duncan Tweed, Genevieve Helen Wills, Angela M Crook, et al.
Implementation Science : IS
|
August 14, 2020
Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda
Jillian L Kadota, Allan Musinguzi, Juliet Nabunje, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 18, 2015
A Step toward an Optimized Rifampin Dose Completed
Martin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
BMC Infectious Diseases
|
July 13, 2018
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study
Conor D Tweed, Angela M Crook, Evans I Amukoye, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 6, 2015
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis
Martin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 286) with videos related to
Sort By:
Page
of 29
The Journal of Antimicrobial Chemotherapy
|
March 28, 2025
Population pharmacokinetics and exposure-response relationship of the antituberculosis drug BTZ-043
Simon E Koele, Norbert Heinrich, Veronique R De Jager, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 7, 2024
Diagnostic accuracy of TB screening tests in a prospective multinational cohort: Chest-X-ray with computer-aided detection, Xpert TB host response, and C-reactive protein
Rebecca Crowder, Balamugesh Thangakunam, Alfred Andama, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2023
Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
Ralf Stemkens, Veronique de Jager, Rodney Dawson, et al.
The New England Journal of Medicine
|
March 14, 2019
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew J Nunn, Patrick P J Phillips, Sarah K Meredith, et al.
BMC Infectious Diseases
|
August 17, 2017
Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil
D M P Ramalho, P F C Miranda, M K Andrade, et al.
BMC Medicine
|
March 30, 2018
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
Conor Duncan Tweed, Genevieve Helen Wills, Angela M Crook, et al.
Implementation Science : IS
|
August 14, 2020
Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda
Jillian L Kadota, Allan Musinguzi, Juliet Nabunje, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 18, 2015
A Step toward an Optimized Rifampin Dose Completed
Martin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
BMC Infectious Diseases
|
July 13, 2018
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study
Conor D Tweed, Angela M Crook, Evans I Amukoye, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 6, 2015
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis
Martin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
Page
of 29